Value Bridge — TULANE UNIVERSITY HOSPITAL & CLINICS
Current $-69M → Target $-58M (+$10.8M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-69.0M
Current EBITDA
$-58.1M
Target EBITDA
+$10.8M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.5M
Payer Mix Optimization
$5.9M
Cost to Collect Reduction
$2.0M
Clean Claim Improvement
$1.5M
Volume & Rate Growth
$9.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-69M to $-58M. The highest-impact lever is Volume & Rate Growth at $3.9M probability-weighted.
IC talking point: "We see $11M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $119M in equity value creation."